Differentiating Probiotics and Prebiotics in Terms of Mechanism of Action and Clinical Application
DOI:
https://doi.org/10.12775/QS.2025.41.60342Keywords
probiotics, prebiotics, gut microbiota, clinical applications, microbiome, gastrointestinal health, immune modulation, synbioticsAbstract
This systematic review explores the key differences between probiotics and prebiotics in terms of their mechanisms of action and clinical applications. Probiotics are live microorganisms that confer health benefits when consumed in adequate amounts, whereas prebiotics are non-digestible food ingredients that promote the growth of beneficial gut bacteria. The review highlights how these two categories of microbiota-targeted interventions work independently and synergistically to maintain and improve human health. A detailed examination of their impact on gastrointestinal health, metabolic disorders, immune function, neurological health, and more is provided. The clinical efficacy of specific probiotic strains and prebiotic compounds is also evaluated. This comprehensive overview aims to inform both clinical practice and future research on microbiota modulation strategies.
References
1. Hill C, Guarner F, Reid G, et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11(8):506-514.
2. Gibson GR, Hutkins R, Sanders ME, et al. The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol. 2017;14(8):491-502.
3. Ouwehand AC, Salminen S, Isolauri E. Probiotics: an overview of beneficial effects. Antonie Van Leeuwenhoek. 2002;82(1-4):279-289.
4. Morrison DJ, Preston T. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes. 2016;7(3):189-200.
5. Ford AC, Harris LA, Lacy BE, Quigley EMM, Moayyedi P. Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome. Aliment Pharmacol Ther. 2018;48(10):1044-1060.
6. Homayouni A, Bastani P, Ziyadi S, et al. Effects of probiotics on the recurrence of bacterial vaginosis: a review. J Low Genit Tract Dis. 2014;18(1):79-86. doi:10.1097/LGT.0b013e31829156ec.
7. Romijn JA, Corssmit EP, Havekes LM, Pijl H. Gut–brain axis. Curr Opin Clin Nutr Metab Care. 2008;11(4):518-521.
8. Kobyliak N, Falalyeyeva T, Mykhalchyshyn G, Bodnar P, Beregova T. Probiotics and nutraceuticals in non-alcoholic fatty liver disease: a comparative overview. World J Gastroenterol. 2016;22(16):3553-3565.
9. West NP, Pyne DB, Cripps AW, et al. Probiotic supplementation for respiratory and gastrointestinal illness symptoms in healthy physically active individuals. Clin Nutr. 2014;33(4):581-587.
10. Ouwehand AC, Tiihonen K, Saarinen M, et al. Influence of a combination of probiotics and prebiotics on intestinal colonization and tolerance in infants. J Pediatr Gastroenterol Nutr. 2009;48(5):536-544.
11. Davani-Davari D, Negahdaripour M, Karimzadeh I, et al. Prebiotics: Definition, Types, Sources, Mechanisms, and Clinical Applications. Foods. 2019;8(3):92. Published 2019 Mar 9. doi:10.3390/foods8030092
12. McFarland LV. Meta-analysis of probiotics for the prevention of traveler’s diarrhea. Travel Med Infect Dis. 2007;5(2):97–105.
13. Sanders ME, Merenstein DJ, Reid G, Gibson GR, Rastall RA. Probiotics and prebiotics in intestinal health and disease: from biology to the clinic [published correction appears in Nat Rev Gastroenterol Hepatol. 2019 Oct;16(10):642. doi: 10.1038/s41575-019-0199-6.]. Nat Rev Gastroenterol Hepatol. 2019;16(10):605-616. doi:10.1038/s41575-019-0173-3
14. Servin AL. Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbiol Rev. 2004;28(4):405-440. doi:10.1016/j.femsre.2004.01.003
15. Chapman CM, Gibson GR, Rowland I. Health benefits of probiotics: are mixtures more effective than single strains?. Eur J Nutr. 2011;50(1):1-17. doi:10.1007/s00394-010-0166-z
16.Anderson RC, Cookson AL, McNabb WC, Park Z, McCann MJ, Kelly WJ, Roy NC. Lactobacillus plantarum MB452 enhances the function of the intestinal barrier by increasing the expression of genes involved in tight junction formation. BMC Microbiol. 2010;10:316.
17. Sanders ME, Guarner F, Guerrant R, et al. An update on the use and investigation of probiotics in health and disease. Gut. 2013;62(5):787-796. doi:10.1136/gutjnl-2012-302504
18. Simon E, Călinoiu LF, Mitrea L, Vodnar DC. Probiotics, Prebiotics, and Synbiotics: Implications and Beneficial Effects against Irritable Bowel Syndrome. Nutrients. 2021 Jun 20;13(6):2112. doi: 10.3390/nu13062112. PMID: 34203002; PMCID: PMC8233736.
19. Szajewska H, Skórka A, Dylag M. Meta-analysis: Saccharomyces boulardii for treating acute diarrhea in children. Aliment Pharmacol Ther. 2007;25(3):257-264.
20. Tursi A, Brandimarte G, Papa A, et al. Treatment of relapsing mild-to-moderate ulcerative colitis with VSL#3. Am J Gastroenterol. 2010;105(10):2218–2227.
21. Rolfe VE, Fortun PJ, Hawkey CJ, Bath-Hextall F. Probiotics for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev. 2006;(4):CD004826.
22. Messaoudi M, Lalonde R, Violle N, et al. Assessment of psychotropic-like properties of a probiotic formulation. Br J Nutr. 2011;105(5):755–764.
23. Wallace CJK, Milev R. The effects of probiotics on depressive symptoms in humans: a systematic review. Ann Gen Psychiatry. 2017;16:14.
24. Wang HT, Anvari S, Anagnostou K. The Role of Probiotics in Preventing Allergic Disease. Children (Basel). 2019;6(2):24. Published 2019 Feb 5. doi:10.3390/children6020024
25. Ogunrinola GA, Oyewale JO, Oshamika OO, Olasehinde GI. The Human Microbiome and Its Impacts on Health. Int J Microbiol. 2020 Jun 12;2020:8045646. doi: 10.1155/2020/8045646. PMID: 32612660; PMCID: PMC7306068.
26. Markowiak P, Śliżewska K. Effects of Probiotics, Prebiotics, and Synbiotics on Human Health. Nutrients. 2017 Sep 15;9(9):1021. doi: 10.3390/nu9091021. PMID: 28914794; PMCID: PMC5622781.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Marlena Jankowska, Karolina Baran , Natalia Jańczyk , Katarzyna Bartnik , Jakub Pokrzepa , Michał Presak , Adrianna Pacołta , Marcelina Nalepka , Mikołaj Pograniczny , Adrianna Mielżyńska
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 102
Number of citations: 0
